Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Varian, Inc. attracted to MR supplier

This article was originally published in The Gray Sheet

Executive Summary

$32 mil. purchase of UK-based Magnex Scientific follows September acquisition of Digilab spectroscopy assets for $14 mil., marking step toward Varian's goal of executing $150 mil. in combinations over three years, Palo Alto firm says Oct. 11. Over that period, Varian aims to generate $1 bil. in annual revenue from scientific instruments and grow operating margins from 11% to 15%. "A trend of MR imaging has been ever-increasing field strength that requires larger and larger magnets," CEO Garry Rogerson explains. "If we are to integrate the magnets into the total system, we need to have control of the development and cost." The Magnex deal includes potential milestone payments for three years. Varian estimates Magnex shipments will total $25 mil.-$28 mil. over 12 months, with roughly 7%-8% likely to support scientific instruments R&D...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel